Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-23

Clinical Trial Update: PARADISE: Predicting AF After Cardiac Surgery

View source ↗

Summary

PARADISE is an Oxford-led clinical trial to predict new-onset atrial fibrillation after cardiac surgery. The current status is unknown and no results are report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oxford | Conditions: Atrial Fibrillation New Onset | Status: UNKNOWN